Merck ’s MRK stock has declined around 10.3% in the past three months, losing almost $32 billion of its market value.

Charlie CY Yang, an analyst from Bank of America Securities, maintained the Buy rating on Merck & Company (MRK – Research Report).

Deep-pocketed investors have adopted a bullish approach towards Merck & Co MRK, and it's something market players shouldn't ...

Along with breast cancer, cervical cancer is among the most feared cancer diagnoses for women around the world.

Insights from analysts' 12-month price targets are revealed, presenting an average target of $144.12, a high estimate of $155 ...

Low-volatility stocks are attractive now because they provide stability and reduce risk during market downturns, delivering ...

1 “We look forward to seeing who has mastered the fine art of marketing among entries this year, all of which are submitted ...

According to recently unveiled statistics by Future Market Insights, the global animal artificial insemination market is set ...

Merck Animal Health recently awarded $90,000 in scholarships to nine aspiring bovine veterinarians in collaboration with the ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.